Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clever Culture Systems has commercialized the APAS Independence platform, an AI-powered automated culture plate reader for environmental monitoring in pharmaceutical manufacturing and clinical microbiology. The system has received multiple global regulatory clearances including FDA, CE Mark, and TGA. It is adopted by major pharmaceutical companies such as AstraZeneca and Bristol Myers Squibb as well as CDMOs like Thermo Fisher Scientific. The company continues to expand its product capabilities with new modules such as contact plate analysis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clever Culture Systems.